Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years-Reference-Cited by-同舟云学术

Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years

Published:2015-06-30 Issue:12 Volume:30 Page:2150-2157
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Palomo Telma¹,Fassier François¹,Ouellet Jean¹,Sato Atsuko¹,Montpetit Kathleen¹,Glorieux Francis H¹,Rauch Frank¹

Affiliation:

1. Shriners Hospital for Children and McGill University; Montreal Quebec Canada

Funder

This work was supported by grants from the Chercheur-Boursier Clinicien program of the Fonds de Recherche du Québec - Santé (to FR); and the Shriners of North America.

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.2567/fullpdf

Reference38 articles.

1. New perspectives on osteogenesis imperfecta;Forlino;Nat Rev Endocrinol.,2011

2. Osteogenesis imperfecta;Rauch;Lancet.,2004

3. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta;Glorieux;N Engl J Med.,1998

4. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta;Astrom;Arch Dis Child.,2002

5. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age;Plotkin;J Clin Endocrinol Metab.,2000

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence;Frontiers in Endocrinology;2024-01-25

2. Safety and Efficacy of Denosumab in Children With Osteogenesis Imperfecta—the First Prospective Comparative Study;The Journal of Clinical Endocrinology & Metabolism;2024-01-10

3. Moving Beyond the 2018 Minimum International Care Considerations for Osteoporosis Management in Duchenne Muscular Dystrophy (DMD): Meeting Report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022;Journal of Neuromuscular Diseases;2024-01-02

4. Clinical Characteristics and Therapeutic Management of Osteogenesis Imperfecta in Iraqi Children;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2023-12-22

5. Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents: A Global Expert Guidance Document;The Journal of Clinical Endocrinology & Metabolism;2023-12-02